STAT

NOVEMBER 16, 2023

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new phase of genetic medicine.   The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise.

Drug Development 363

Drug Development 363

PharmaVoice

NOVEMBER 16, 2023

Dr. Paul Moss, a hematology expert in the U.K., conducted a study with AstraZeneca showing the alarming extent to which immunocompromised patients are burdened with COVID-19.

290

290

STAT

NOVEMBER 16, 2023

BAD RIVER RESERVATION, Wis. — Sunlight is streaming through holes in the walls of a disused, corrugated metal shack, revealing its modest insides: Dirt floors, stacks of two-by-fours, and a pile of Little Caesars pizza boxes under attack by a work crew on lunch break. This building is clearly not ready to be a home. But in the next 24 hours, it must become one.

362

362

PharmaVoice

NOVEMBER 16, 2023

The 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and muscular dystrophy drugs.

147

147

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 16, 2023

A dangerous decline in the rate of children vaccinated against measles is spurring a global increase in cases and deaths from the highly contagious virus, according to a report released Thursday. Estimated measles cases rose 18% to 9 million in 2022 when compared to the previous year, and deaths rose by 43% to 136,200, according to the report , jointly authored by the World Health Organization and the Centers for Disease Control and Prevention.

Vaccines 356

Vaccines 356

Big Molecule Watch

NOVEMBER 16, 2023

Earlier today, UK’s Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorization to Vertex Pharmaceuticals and CRISPR Therapeutics for their CRISPR/Cas9 gene therapy, CASGEVY (exagamglogene autotemcel), marking the world’s first regulatory approval for a CRISPR-based gene-edited therapy. CASGEVY is the first medicine to be licensed that uses the innovative gene-editing tool CRISPR.

116

116

The Pharmacist

NOVEMBER 16, 2023

All suitably trained members of the pharmacy team will be able to deliver blood pressure checks from 1 December, it has been announced today. And there will be a 'renewed focus' on ambulatory blood pressure monitoring, helping to identify even more people at risk of heart attack and stroke, the pharmacy negotiator said. Currently, under […] The post More pharmacy staff able to deliver blood pressure checks from December appeared first on The Pharmacist.

111

111

STAT

NOVEMBER 16, 2023

In 1993, I published “Listening to Prozac,” a book that grew out of my clinical experience prescribing what was then a new class of medications, ones thought to moderate depression through their effect on the way that the brain handles the neurotransmitter serotonin. Some of my patients had reported marked favorable reactions to the drugs — first Prozac and, soon after, Zoloft.

333

333

The Pharmacist

NOVEMBER 16, 2023

The first electronic prescription service (EPS) in Wales has launched today, allowing patients and healthcare professionals to benefit from ‘easier, safer and more efficient’ prescribing and dispensing, the Welsh Government has said. Instead of printing, signing and giving a patient a paper form to take to a pharmacy, GPs will be able to send the […] The post Wales launches first electronic prescription service appeared first on The Pharmacist.

111

111

STAT

NOVEMBER 16, 2023

Three months ago, my aunt Margaret had a stroke. Days before, she was repainting her bathroom and driving herself. Now, she needs help with dressing and getting in and out of bed, and our family is grappling with the fact that this fiercely self-sufficient woman will never live independently again. This health crisis has been compounded at every turn by failures of the health care system — failures that are particularly infuriating to me because I have devoted my life to solving these ver

Compounding 314

Compounding 314

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

NOVEMBER 16, 2023

Clearance of Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy in the U.K. comes ahead of expected regulatory decisions in the U.S. and Europe.

120

120

STAT

NOVEMBER 16, 2023

Dr. Reddy’s Laboratories, one of the world’s largest generic drugmakers, was cited by the U.S. Food and Drug Administration for a host of manufacturing violations at one of its plants in India, the latest instance in which the company was tagged by the regulator for quality-control problems. In a recent inspection report , the agency found several notable failures, such as major production equipment that was not appropriately cleaned; a quality-control unit that did not investigate

291

291

The Pharmacist

NOVEMBER 16, 2023

Community pharmacists will be able access and add to patient records currently maintained by GPs from January next year, in a bid to free up millions of GP appointments. The Government, NHS England and Community Pharmacy England said they agreed that the Pharmacy First scheme will launch on 31 January 2024, subject to the ‘appropriate digital […] The post Community pharmacists to gain greater access to GP record from January appeared first on The Pharmacist.

Community Pharmacies 106

Community Pharmacies 106

STAT

NOVEMBER 16, 2023

More than a tenth of fecal immunochemical tests, used for routine colorectal cancer screening, contained samples that could not be processed by labs, according to a study published this week in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research. This is over twice the amount recommended by the U.S.

275

275

Pharma Times

NOVEMBER 16, 2023

The bacteriocin development programme will first target pseudomonas aeruginosa - News - PharmaTimes

136

136

STAT

NOVEMBER 16, 2023

The Food and Drug Administration on Wednesday approved a new treatment for people with non-small cell lung cancer that contains a rare genetic alteration called Ros1. The genetically targeted medicine, called Augtyro, will be sold by Bristol Myers Squibb. It was developed by a small biotech company, Turning Point Therapeutics, that was acquired by Bristol in June 2022.

259

259

pharmaphorum

NOVEMBER 16, 2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.

105

105

STAT

NOVEMBER 16, 2023

Advances in  childhood cancer  are a success story in modern medicine. But in the past decade, those strides have stalled for Black and Hispanic youth, opening a gap in death rates, according to a new report published Thursday. Childhood cancers are rare and treatments have improved drastically in recent decades, saving lives.

256

256

Pharma Times

NOVEMBER 16, 2023

The funding will be used to develop new diagnostic tests, treatments and devices - News - PharmaTimes

130

130

STAT

NOVEMBER 16, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with an update on a thwarted gene therapy study, a head-to-head fight in GLP-1, and a critical look at Alzheimer’s treatment.

199

199

PharmExec

NOVEMBER 16, 2023

Emerging technologies like digital twins offer supply chain efficiency solutions, allowing the industry to integrate sustainable practices while ensuring patient safety.

105

105

STAT

NOVEMBER 16, 2023

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability.

191

191

BioPharma Dive

NOVEMBER 16, 2023

Acquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top sellers.

105

105

STAT

NOVEMBER 16, 2023

Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are racing about the Pharmalot grounds and the parade of vehicles outside our window is picking up. As for us, we are dutifully firing up the coffee kettle to brew another cup of needed stimulation. Our choice today is butter pecan. Please feel free to join us.

Drug Pricing 160

Drug Pricing 160

BioPharma Dive

NOVEMBER 16, 2023

Red Tree Venture Capital plans to tap into San Diego’s biotech pipeline as it works to build a West Coast competitor to Boston-area investors.

108

108

European Pharmaceutical Review

NOVEMBER 16, 2023

Casgevy (exagamglogene autotemcel), also known as exa-cel, is the first treatment to be licensed that uses CRISPR. It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia.

96

96

BioPharma Dive

NOVEMBER 16, 2023

The deal, which will result in a combined company operating under Q32's name, comes months after Homology laid off much of its staff and halted research.

104

104

Pharmaceutical Technology

NOVEMBER 16, 2023

Vertex and CRISPR's Casgevy has received conditional approval in the UK for treating sickle cell and transfusion-dependent beta-thalassemia.

105

105

BioPharma Dive

NOVEMBER 16, 2023

The company, which is working with regulators to lift a clinical hold, said the treatment could still help people with X-linked myotubular myopathy.

103

103

The Pharmacist

NOVEMBER 16, 2023

Payments for Pharmacy First, the expanded Pharmacy Contraception Service and the re-launched blood pressure check service will be ‘bundled’ together by March 2025, meaning pharmacies will have to provide all three to be eligible for funding. It was confirmed today that the highly anticipated Pharmacy First service is set to launch at the end of […] The post Pharmacy First: Services ‘bundle’ required by March 2025 for monthly payments appeared first on The Pharmacist.

98

98

European Pharmaceutical Review

NOVEMBER 16, 2023

While Europe has historically been a pioneer in the adoption of biosimilars, a new report by the global initiative Act4Biosimilars has revealed differences country by country, including disparities between Eastern and Western Europe. This is based on research from a report published in April this year by IQVIA. [Act4Biosimilars’ Regional Deep Dive Report Europe] noted that biosimilar adoption levels vary significantly across Europe” Act4Biosimilars shared that their Deep Dive Report

Biosimilars 91

Biosimilars 91

PharmExec

NOVEMBER 16, 2023

Express Scripts has announced plans to offer to a new pharmacy network cost-based pricing option for prescription medications and pharmacy services.

Drug Pricing 98

Drug Pricing 98

PharmaTech

NOVEMBER 16, 2023

Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore. manufacturing facility.

105

105

Pharmaceutical Technology

NOVEMBER 16, 2023

Ardelyx scores another FDA win after Xphyozah was approved by the FDA in October as an add-on therapy for chronic kidney disease patients.

98

98

Outsourcing Pharma

NOVEMBER 16, 2023

The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project ideas to drive industry change.

98

98